ATRIA
发表于 2025-3-28 17:53:49
http://reply.papertrans.cn/17/1602/160168/160168_41.png
Kindle
发表于 2025-3-28 20:08:33
http://reply.papertrans.cn/17/1602/160168/160168_42.png
无可争辩
发表于 2025-3-29 01:24:04
http://reply.papertrans.cn/17/1602/160168/160168_43.png
receptors
发表于 2025-3-29 04:43:18
Nonparametric Covariate Adjustment for the Youden Indexpular summary index of the ROC curve. In some diagnostic studies, it is believed that the impact of covariates might influence the accuracy of the diagnostic test. In regards to this consideration, we propose nonparametric estimates for the YI with covariate adjustment for the test results under het
Nonporous
发表于 2025-3-29 11:15:58
http://reply.papertrans.cn/17/1602/160168/160168_45.png
大暴雨
发表于 2025-3-29 12:23:50
http://reply.papertrans.cn/17/1602/160168/160168_46.png
ethereal
发表于 2025-3-29 17:37:22
Collective Evidence in Drug Evaluationicity adjustments within one study to control the type I error rate. The use of multiplicity adjustment procedures (MAPs) sometimes leads to conclusions that may not seem logical. As drug efficacy evaluation involves aspects such as assessing efficacy, selecting optimal doses, and labeling claims, i
paltry
发表于 2025-3-29 21:49:04
http://reply.papertrans.cn/17/1602/160168/160168_48.png
无底
发表于 2025-3-30 01:51:58
http://reply.papertrans.cn/17/1602/160168/160168_49.png
爵士乐
发表于 2025-3-30 07:58:36
Inferiority Index, Margin Functions, and Hybrid Designs for Noninferiority Trials with Binary Outcomiateness of a fixed margin. The two-step fixed margin approach recommended in the Food and Drug Administration (FDA) guidance to industry on NI trials (US FDA, Guidance to industry: non-inferiority clinical trials, 2010) relies on the availability of relevant historical data and expert clinical know